Medical specialists from China tagged as investigators in clinical trials studying Prediabetic State
Total 20 results
-
Feng Bai, MDSeen in:
- Qinghai, Lanzhou, Lanzhou University Second Hospital
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Heping Gu, MDSeen in:
- Henan, Zhengzhou, First Affiliated Hospital of Zhengzhou University
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Huairong ZhangSeen in:
- Shaanxi, Xi'an, The First Affiliated Hospital of Xi'an Jiaotong University
Trials:- NCT02826759 (Principal Investigator)
Conditions: -
Jiawang Ding, MDSeen in:
- Hubei, Yichang, Yichang Central Hospital
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Jun Tao, MD,PhDSeen in:
- Guangdong, Guangzhou, First Affiliated Hospital,Sun Yat-sen University
Trials:- NCT03532620 (Principal Investigator)
- NCT04903210 (Principal Investigator)
Conditions: -
Lan Zhao, MDSeen in:
- Shandong, Yantai, Yantaishan Hospital, Yantai
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Li Feng, MDSeen in:
- Guangdong, Zhongshan, People's Hospital of Zhongshan City
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Liangkai Chen, MDSeen in:
- Hubei, Wuhan, Huazhong University of Science and Technology
Trials:- NCT03495362 (Principal Investigator)
- NCT03316612 (Principal Investigator)
Conditions: -
Qiang Wang, MDSeen in:
- Hubei, Wuhan, Huazhong University of Science and Technology
Trials:- NCT03495362 (Principal Investigator)
- NCT03316612 (Principal Investigator)
Conditions: -
Ruihua Yue, MDSeen in:
- Chongqing, Chongqing, Fourth People's Hospital of Chongqing
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Ruxing Wang, MDSeen in:
- Jiangsu, Wuxi, Wuxi People's Hospital
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Shenghu He, MDSeen in:
- Jiangsu, Yangzhou, Subei People's Hospital of Jiangsu province
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Shufang Xu, PhDSeen in:
- Hubei, Wuhan, Huazhong University of Science and Technology
Trials:- NCT03495362 (Principal Investigator)
Conditions: -
Wenchao Qu, MDSeen in:
- Guangdong, Guangzhou, Second Affiliated Hospital of Guangzhou Medical University
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Xiaoli Hu, MDSeen in:
- Hubei, Wuhan, Huazhong University of Science and Technology
Trials:- NCT03495362 (Principal Investigator)
- NCT03316612 (Principal Investigator)
Conditions: -
Xiaolong Zhao, PhDSeen in:
- Shanghai, Shanghai, Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV: A Randomized Controlled Trial.
- Shanghai, Shanghai, Xiaolong Zhao
Trials:- NCT05135039 (Principal Investigator)
- NCT05641337 (Principal Investigator)
Conditions: -
Xin Jiang, MDSeen in:
- Guangdong, Shenzhen, Shenzhen People's Hospital
Trials:- NCT03532620 (Principal Investigator)
Conditions: -
Xinli Zhou, MD,PhDSeen in:
- Shandong, Jinan, Shandong Provincial Hospital
Trials:- NCT01960205 (Principal Investigator)
Conditions: -
Xinyue Xu, masterSeen in:
- Shanghai, Shanghai, Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV: A Randomized Controlled Trial.
Trials:- NCT05135039 (Sub-Investigator)
Conditions: -
Yongguang Zhang, MDSeen in:
- Jiangsu, Taizhou, Taizhou Hospital of TCM
Trials:- NCT03532620 (Principal Investigator)
Conditions:
Clinical Trials on Prediabetic State
-
Aga Khan UniversityUniversity of Helsinki; International Diabetes FederationUnknownPrediabetic State & High Risk IndividualsPakistan
-
Ingredia S.A.BioTeSys GmbHCompletedPrediabetic StateGermany
-
Dexa Medica GroupCompleted
-
Gadjah Mada UniversityUniversitas Islam IndonesiaRecruitingPreDiabetes | Prediabetic StateIndonesia
-
Riphah International UniversityCompleted
-
Universidad Católica San Antonio de MurciaCompleted
-
National Research Council, SpainCompleted
-
InLight SolutionsCompletedHealthy | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Prediabetic State (IGT)United States
-
Centro Universitario de Ciencias de la Salud, MexicoRecruiting
-
Shri Ramachandra Bhanj Medical CollegeCompleted